📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Weekly dihydroartemisinin-piperaquine versus monthly sulfadoxine-pyrimethamine for malaria chemoprevention in children with sickle cell anaemia in Uganda and Malawi (CHEMCHA): a randomised, double-blind, placebo-controlled trial. (2025)

First Author: Idro R

Attributed to: R Idro, Makerere University - The pathogenesis and treatment of nodding syndrome funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/s1473-3099(24)00737-0

PubMed Identifier: 39718172

Publication URI: http://europepmc.org/abstract/MED/39718172

Type: Journal Article/Review

Volume: 25

Parent Publication: The Lancet. Infectious diseases

Issue: 6

ISSN: 1473-3099